Abstract
This report aims to provide a general description of the cardiovascular effects of dexmedetomidine, emphasizing its effects on conduction, and to give an evidence-based review of the literature regarding the use of dexmedetomidine to treat and prevent tachyarrhythmias in infants and children. A computerized bibliographic search of the literature on the use of dexmedetomidine to treat and prevent arrhythmias in infants and children was conducted. The cardiovascular effects of dexmedetomidine have been well studied in animal and adult human models. Growing experience, mostly in the pediatric population, has demonstrated the potential therapeutic applications of dexmedetomidine in the acute treatment of arrhythmias. Additionally, its use during cardiac surgery has been associated with a decreased incidence of postoperative ventricular and supraventricular tachyarrhythmias. Although dexmedetomidine is not currently approved by the Food and Drug Administration for the pediatric population, findings have shown it to be effective in various clinical scenarios for sedation. In addition, recent studies show that dexmedetomidine may have promising properties for the acute treatment and prevention of tachyarrhythmias.
Similar content being viewed by others
References
Berkenbosch JW, Tobias JD (2003) Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 4:203–205
Bharati S, Pal A, Biswas C, Biswas R (2011) Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: a case series and review of published case reports. Acta Anaesthesiol Taiwan 49:165–167
Chrysostomou C, Beerman L, Shiderly D et al (2008) Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesth Analg 107:1514–1522
Chrysostomou C, Komarlu R, Lichtenstein S, Shiderly D, Arora G, Orr R, Wearden PD, Morell VO, Munoz R, Jooste EH (2010) Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease. Intensive Care Med 36:836–842
Chrysostomou C, Sanchez-de-Toledo J, Wearden P et al (2011) Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations. Ann Thorac Surg 92:964–972
Chrysostomou C, Morell VO, Wearden P et al (2013) Dexmedetomidine: therapeutic use for the termination of reentrant tachycardia. Congenit Heart Dis 8(1):48–56
Delwadia S, Naguib A, Tobias J (2012) Dexmedetomidine controls supraventricular tachycardia following cardiac surgery in a child. World J Pediatr Congenit Heart Surg 3:406–409
Deutsch E, Tobias JD (2007) Hemodynamic and respiratory changes following dexmedetomidine administration during general anesthesia: sevoflurane vs desflurane. Paediatr Anaesth 17:438–444
Finkel JC, Quezado ZMN (2007) Hypothermia-induced bradycardia in a neonate receiving dexmedetomidine. J Clin Anesth 19:290–292
Gerlach AT, Murphy CV (2009) Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: case report and review of the literature. Pharmacotherapy 29:1492–1494
Hammer GB, Drover DR, Jackson E (2008) The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg 106:79–83
Hayashi Y, Sumikawa K, Maze M, Yamatodani A, Kamibayashi T, Kuro I (1991) Dexmedetomidine prevents epinephrine induced arrhythmias through stimulation of central alpha two adrenoreceptors in halothane anesthetized dogs. Anesthesiology 75:113–117
Herr DL, Sum-Ping ST, England M (2003) ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 17:576–584
Ingersoll-Weng E, Manecke GR, Thistlethwaite PA (2004) Dexmedetomidine and cardiac arrest. Anesthesiology 100:738–739
Jalonen J, Hynynen M, Kuitunen A, Heikkilä H, Perttilä J, Salmenperä M, Valtonen M, Aantaa R, Kallio A (1997) Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 86:331–345
Jooste EH, Muhly WT, Ibinson JW et al (2010) Acute hemodynamic changes following rapid intravenous bolus dosing of dexmedetomidine in pediatric heart transplant patients undergoing routine cardiac catheterization. Anesth Analg 111:1490–1496
Kamibayashi T, Hayashi Y, Mammoto T, Yanatodani A, Sumikawa K, Yoshiya I (1995) Role of the vagus nerve in the antidysrhythmic effects of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology 83:992–999
LeRiger M, Naguib A, Galantowicz M, Tobias JD (2012) Dexmedetomidine controls junctional ectopic tachycardia during tetralogy of Fallot repair in an infant. Ann Card Anaesth 15:224–228
Mason KP, Zurakowski D, Zgleszewski SE et al (2008) High-dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 18:403–411
Ohsugi E, Nagamine Y, Ohtsuka M (2011) The effect of dexmedetomidine in a child with intractable supraventricular tachyarrhythmias after total cavopulmonary connection. Masui 60:493–495
Parent B, Munoz R, Shiderly D, Chrysostomou C (2010) Use of dexmedetomidine in sustained ventricular tachycardia. Anaesth Intensive Care 38:781–782
Ruesch S, Levy JH (2002) Treatment of persistent tachycardia with dexmedetomidine during off-pump cardiac surgery. Anesth Analg 95:316–318
Salmenpera MT, Szlam F, Hug CC Jr (1993) Anesthetic and hemodynamic interactions of dexmedetomidine and fentanyl in dogs. Anesthesiology 78:813–820
Scheinin H, Jaakola ML, Sjövall S, Ali-Melkkilä T, Kaukinen S, Turunen J, Kanto J (1993) Intramuscular dexmedetomidine as premedication for general anesthesia: a comparative multicenter study. Anesthesiology 78:1065–1107
Shah A, Koneru J, Nicoara A et al (2007) Dexmedetomidine-related cardiac arrest in a patient with permanent pacemaker: a cautionary tale. PACE 30:1158–1160
Shepherd SM, Tejman-Yarden S, Khanna S et al (2011) Dexmedetomidine-related atrial standstill and loss of capture in a pediatric patient after congenital heart surgery. Crit Care Med 39:187–189
Sichrovsky TC, Mittal S, Steinberg JS (2008) Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg 106:1784–1786
Snapir A, Posti J, Kentala E et al (2006) Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology 105:902–910
Tobias JD (2007) Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med 8:115–131
Tobias JD (2008) Bradycardia during dexmedetomidine and therapeutic hypothermia. J Intensive Care Med 23:403–408
Tobias JD, Gupta P, Naguib A, Yates A (2011) Dexmedetomidine: applications in the pediatric patient with congenital heart disease. Pediatr Cardiol 32:1075–1087
Wang H, Han H, Zhang L et al (2001) Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart. Mol Pharmacol 59:1029–1036
Zhang X, Schmidt U, Wain JC, Bigatello L (2010) Bradycardia leading to asystole during dexmedetomidine infusion in an 18-year-old double-lung transplant recipient. J Clin Anesth 22:45–49
Acknowledgments
We thank Dr. Angelo Rutty from the Heart Institute at the Children’s Hospital of Pittsburgh for the illustration.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tobias, J.D., Chrysostomou, C. Dexmedetomidine: Antiarrhythmic Effects in the Pediatric Cardiac Patient. Pediatr Cardiol 34, 779–785 (2013). https://doi.org/10.1007/s00246-013-0659-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-013-0659-7